Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
K33 Research Highlights Unwavering Institutional Demand for Bitcoin
-
$BTC: BitMEX Co-Founder Offers Two Possible Explanations for Bitcoin’s Current Rally
-
Markets Digest The Fed's Hawkish Pause, Wait For ECB
-
Bitcoin ($BTC) Whales Undeterred by Crypto Downturn as Analysts Notice Heavy Accumulation
-
Yusko on BlackRock's Bitcoin ETF & Crypto Future"